Pasithea Therapeutics (KTTA) Total Liabilities (2021 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Total Liabilities for 4 consecutive years, with $823975.0 as the latest value for Q3 2024.
- Quarterly Total Liabilities fell 63.92% to $823975.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $823975.0 through Sep 2024, down 63.92% year-over-year, with the annual reading at $2.7 million for FY2023, 1.36% up from the prior year.
- Total Liabilities hit $823975.0 in Q3 2024 for Pasithea Therapeutics, down from $1.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $4.6 million in Q3 2021 to a low of -$900672.0 in Q1 2021.
- Historically, Total Liabilities has averaged $1.9 million across 4 years, with a median of $2.3 million in 2023.
- Biggest five-year swings in Total Liabilities: surged 430.62% in 2022 and later tumbled 63.92% in 2024.
- Year by year, Total Liabilities stood at $1.9 million in 2021, then surged by 41.14% to $2.7 million in 2022, then grew by 1.36% to $2.7 million in 2023, then plummeted by 69.69% to $823975.0 in 2024.
- Business Quant data shows Total Liabilities for KTTA at $823975.0 in Q3 2024, $1.5 million in Q2 2024, and $2.5 million in Q1 2024.